Back to company

Pharmaforce ApS: Financial statements 2018

CVR: 26394198

Pharmaforce ApS (CVR 26394198) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 3,684,787 and a net result of DKK 1,177,199 compared with DKK 825,691 the year before. That is an increase of 62.8% compared with the year before. Equity amounted to DKK 2,163,545. The solvency ratio was 44.5%. The company had 3 employees in the financial year.

Gross Profit
3,684,787 kr.
Profit/Loss
1,177,199 kr.
Equity
2,163,545 kr.
Total Assets
4,866,144 kr.
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-3.7 mio.1.2 mio.2.2 mio.3
2017-2.3 mio.826 t.986 t.2
2016-1.1 mio.-74 t.161 t.2
2015-312 t.149 t.234 t.-
2014-1.2 mio.896 t.85 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Pharmaforce ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2018

Pharmaforce ApS: The 2017 annual report is outApr 18, 2018

Pharmaforce ApS has published its annual report for 2017. Gross profit came to DKK 2,263,716, and the net result was DKK 825,691.

About Pharmaforce ApS

Pharmaforce ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Mads Louie Frazier. The company is owned by Pfam Holding ApS. The company has 5 employees. In 2025, the company reported a gross profit of DKK 5,238,511 and a net result of DKK 914,232 compared with DKK 1,494,355 the year before. Equity amounted to DKK 4,328,882.